However, decreasing CHOP protein leads to reduction of β-amyloid precursor protein (APP) and β-secretase (BACE1), which cleaves α-β peptide, suggesting that preventing Gadd153 activation protects against AD symptoms related to oxidized cholesterol products [10]. The gene discussed is DDIT3; the disease is Alzheimer disease.